Cypher Sirolimus- Eluting Coronary Stent Comparable to Bypass Surgery
The data was recently presented at the European Society of Cardiology meeting. It is the only drug-eluting stent with such randomised clinical data indicating that it is comparable to bypass surgery for these specific patients. The study showed that after one year no difference from bypass surgery in terms of death, heart attacks or stroke was found. The trial was conducted at 24 medical centres throughout the UK and Ireland.
Print as PDF